Tag: Ibrance

Portrait of a Drug Price: Pfizer’s Ibrance

December 15, 2015

When asked to defend drug prices, the most common answer from a drug company spokesman is that pricing is a “very complex process.” Usually this rhetoric is used to refute … Continue reading Portrait of a Drug Price: Pfizer’s Ibrance